| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 16 |
| 1 | CAPECITABINE | 7 |
| 2 | OXALIPLATIN | 7 |
| 3 | CYCLOPHOSPHAMIDE | 6 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 6 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 6 |
| 6 | FLUOROURACIL | 6 |
| 7 | FLUOROURACIL CREAM, 0.5% | 6 |
| 8 | DOCETAXEL | 5 |
| 9 | DOCETAXEL ANHYDROUS | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLAVOXATE HYDROCHLORIDE | 1 | 0.0099 |
| 1 | ERTUGLIFLOZIN | 1 | 0.0009 |
| 2 | FRUQUINTINIB | 2 | 0.0005 |
| 3 | CALCIUM FOLINATE | 2 | 0.0004 |
| 4 | GLOFITAMAB | 1 | 0.0004 |
| 5 | IOPROMIDE | 1 | 0.0002 |
| 6 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| 7 | REPAGLINIDE | 1 | 0.0001 |
| 8 | BEVACIZUMAB | 16 | 0.0001 |
| 9 | NUSINERSEN | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 1 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 2 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Glinide [EPC] | 1 | 0.0001 |
| 4 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 16 | 0.0001 |
| 6 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |
| 7 | Platinum-based Drug [EPC] | 11 | 0.0000 |
| 8 | Radiographic Contrast Agent [EPC] | 1 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 10 | 0.0000 |